Multidrug resistant Staphylococcus aureus decreased 6 percent from 2011, with 45 percent of hospitals recording to MRSA cases, a 4 percent increase since 2011.
- Central line-associated bloodstream infections decreased 5 percent.
- Vancomycin resistant Enteroccus case numbers remained stable, though the infections were reported in 54 percent of hospitals, 6 percent more than in 2011.
The distribution of infection control successes was uneven, with a 6 percent decrease in infections in general wards, 13 percent decrease in special wards and 22 percent decrease in neonatal intensive care units, according to California Healthline‘s coverage of the report.
More Articles on Quality:
Cardiovascular Rehabilitation at Henry Ford Health: A Case Study
1 in 10 Hospitals Offer Price Transparency
6 Predictions on Global Medication Expenditures by 2017
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
